Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2012 pubmed

Vitamin D and the human antimicrobial peptide LL-37 enhance group a streptococcus resistance to killing by human cells.

Love. John F JF; Tran-Winkler. Hien J HJ; Wessels. Michael R MR

Key Findings

  • LL‑37 signals the GAS CsrRS system, increasing production of the capsule and streptolysin O, which protect the bacteria from killing
  • Higher LL‑37 levels make GAS less likely to be taken up and destroyed by throat epithelial cells, neutrophils, and macrophages
  • Vitamin D raises LL‑37 in macrophages, which surprisingly reduces these immune cells’ ability to control GAS infection

Practical Outcomes

  • If you’re prone to strep infections, be aware that very high vitamin D supplementation could increase LL‑37 and potentially worsen the infection. There’s no clear benefit to deliberately boosting LL‑37 for anti‑infection purposes, and doing so may backfire against GAS. Use vitamin D at recommended levels and monitor for throat infections rather than assuming more is always better.

Summary

The study shows that the human peptide LL‑37, which rises when you take vitamin D, can actually make strep throat bacteria (GAS) tougher for your own cells to kill by turning on the bacteria’s own attack tools. So, boosting LL‑37 (for example with high vitamin D) might unintentionally help the bacteria avoid being destroyed by mouth cells and immune cells.

Abstract

The CsrRS two-component regulatory system of group A Streptococcus (GAS; Streptococcus pyogenes) responds to subinhibitory concentrations of the human antimicrobial peptide LL-37. LL-37 signaling through CsrRS results in upregulation of genes that direct synthesis of virulence factors, including the hyaluronic acid capsule and streptolysin O (SLO). Here, we demonstrate that a consequence of this response is augmented GAS resistance to killing by human oropharyngeal keratinocytes, neutrophils, and macrophages. LL-37-induced upregulation of SLO and hyaluronic acid capsule significantly reduced internalization of GAS by keratinocytes and phagocytic killing by neutrophils and macrophages. Because vitamin D induces LL-37 production by macrophages, we tested its effect on macrophage killing of GAS. In contrast to the reported enhancement of macrophage function in relation to other pathogens, treatment of macrophages with 1α,25-dihydroxy-vitamin D3 paradoxically reduced the ability of macrophages to control GAS infection. These observations demonstrate that LL-37 signals through CsrRS to induce a virulence phenotype in GAS characterized by heightened resistance to ingestion and killing by both epithelial cells and phagocytes. By inducing LL-37 production in macrophages, vitamin D may contribute to this paradoxical exacerbation of GAS infection. IMPORTANCE It remains poorly understood why group A Streptococcus (GAS) causes asymptomatic colonization or localized throat inflammation in most individuals but rarely progresses to invasive infection. The human antimicrobial peptide LL-37, which is produced as part of the innate immune response to GAS infection, signals through the GAS CsrRS two-component regulatory system to upregulate expression of multiple virulence factors. This study reports that two CsrRS-regulated GAS virulence factors-streptolysin O and the hyaluronic acid capsule-are critical in LL-37-induced resistance of GAS to killing by human throat epithelial cells and by neutrophils and macrophages. Vitamin D, which increases LL-37 production in macrophages, has the paradoxical effect of increasing GAS resistance to macrophage-mediated killing. In this way, the human innate immune response may promote the transition from GAS colonization to invasive infection.

Study Information

Provider

pubmed

Year

2012

Date

2012-10-23T00:00:00.000Z

DOI

10.1128/mbio.00394-12